KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Interest Coverage Ratio (2019 - 2025)

Historic Interest Coverage Ratio for Rigel Pharmaceuticals (RIGL) over the last 10 years, with Q3 2025 value amounting to 15.01.

  • Rigel Pharmaceuticals' Interest Coverage Ratio rose 11991.23% to 15.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 15.7, marking a year-over-year increase of 120029.57%. This contributed to the annual value of 3.06 for FY2024, which is 20246.52% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Interest Coverage Ratio stood at 15.01 for Q3 2025, which was up 11991.23% from 32.61 recorded in Q2 2025.
  • Rigel Pharmaceuticals' Interest Coverage Ratio's 5-year high stood at 86.09 during Q1 2021, with a 5-year trough of 22.79 in Q2 2022.
  • Its 5-year average for Interest Coverage Ratio is 1.78, with a median of 2.35 in 2023.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Interest Coverage Ratio crashed by 20717.24% in 2022 and then skyrocketed by 1470019.61% in 2025.
  • Quarter analysis of 5 years shows Rigel Pharmaceuticals' Interest Coverage Ratio stood at 16.49 in 2021, then surged by 111.39% to 1.88 in 2022, then plummeted by 45.11% to 1.03 in 2023, then soared by 726.35% to 8.52 in 2024, then skyrocketed by 76.14% to 15.01 in 2025.
  • Its Interest Coverage Ratio was 15.01 in Q3 2025, compared to 32.61 in Q2 2025 and 6.89 in Q1 2025.